Abstract
In 1985, potassium citrate was approved by the FDA for kidney stone prevention in distal renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis of any etiology and uric acid lithiasis with or without calcium stones. Potassium citrate is now widely used either alone or in combination with thiazide or thiazide analogue diuretics for the treatment of calcium nephrolithiasis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
